Insmed, Inc. (INSM)
149.86
-1.17
(-0.77%)
USD |
NASDAQ |
Feb 06, 16:00
149.01
-0.85
(-0.57%)
Pre-Market: 20:00
Insmed SG&A Expense (TTM) : 631.20M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.181B |
| Biogen, Inc. | 2.434B |
| CorMedix, Inc. | 75.56M |
| Merck & Co., Inc. | 10.73B |
| Pfizer Inc. | 13.79B |